Interaksi Senobamat dan Fenitoin

Senobamat dan Fenitoin: kedua label peresepan menguraikan interaksi yang biasanya memerlukan pemantauan, perubahan dosis, atau pemberian jarak antardosis.

Moderat

Biasanya dapat dikelola dengan pemantauan atau perubahan dosis. Beri tahu apoteker Anda bahwa Anda menggunakan keduanya.

Apa kata label FDA

Dari label Fenitoin (Phenytoin) · berlaku sejak 2024-12-24

Moderat

Limited evidence suggests that HLA-B*1502 may be a risk factor for the development of SJS/TEN in patients of Asian ancestry taking other antiepileptic drugs associated with SJS/TEN, including phenytoin.

Peringatan dan perhatianberdasarkan golongan obatLihat label di DailyMed
Moderat

…defects), and abnormalities characteristic of fetal hydantoin syndrome, including dysmorphic skull and facial features, nail and digit hypoplasia, growth abnormalities (including microcephaly), and cognitive deficits, have been reported among children born to epileptic women who took phenytoin alone or in combination with other antiepileptic drugs during pregnancy.

Peringatan dan perhatianberdasarkan golongan obatLihat label di DailyMed

Dari label Senobamat (Xcopri) · berlaku sejak 2025-08-25

Moderat

Phenytoin: Gradually decrease phenytoin dosage by up to 50%.

Interaksi obatmenyebut FenitoinLihat label di DailyMed
Moderat

…potential for reduced efficacy of these drugs, increase the dosage of lamotrigine or carbamazepine, as needed, when used concomitantly with XCOPRI. carbamazepine ↓ plasma concentrations phenytoin ↑ plasma concentrations Because of a potential 2-fold increase in phenytoin levels, gradually decrease phenytoin dosage by up to 50% as XCOPRI is being titrated. phenobarbital…

Interaksi obatmenyebut FenitoinLihat label di DailyMed
Moderat

Concomitant use with other CNS depressants or alcohol may have additive effects.

Peringatan dan perhatianberdasarkan golongan obatLihat label di DailyMed
Moderat

Anyone considering prescribing XCOPRI or any other AED must balance this risk with the risk of untreated illness.

Peringatan dan perhatianberdasarkan golongan obatLihat label di DailyMed
Moderat

Patients should be carefully observed for signs of central nervous system (CNS) depression, such as somnolence and sedation, when XCOPRI is used with other drugs with sedative properties because of potential additive effects.

Peringatan dan perhatianberdasarkan golongan obatLihat label di DailyMed

Menggunakan lebih dari dua obat ini? Interaksi saling bertumpuk. Periksa seluruh daftar Anda sekaligus; daftar itu tetap berada di peramban Anda.

Buka di pemeriksa

Bukan nasihat medis. Interaction Checker mengutip teks label FDA dan lembar fakta NIH. Penting atau tidaknya suatu interaksi bagi Anda bergantung pada dosis, waktu penggunaan, fungsi ginjal dan hati, serta kondisi lain. Pastikan dengan apoteker atau dokter yang meresepkan.